Mechanisms of androgen-refractory prostate cancer.

被引：427

作者：

Debes, JD ^{[1
]}

Tindall, DJ

机构：

[1] Mayo Clin, Coll Med, Dept Urol, Rochester, MN 55905 USA

[2] Mayo Clin, Coll Med, Dept Biochem, Rochester, MN USA

[3] Mayo Clin, Coll Med, Dept Mol Biol, Rochester, MN USA

来源：

关键词：

D O I：

10.1056/NEJMp048178

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1488 / 1490

页数：3

共 3 条

[1] Molecular determinants of resistance to antiandrogen therapy
Chen, CD
Welsbie, DS
Tran, C
Baek, SH
Chen, R
Vessella, R
Rosenfeld, MG
Sawyers, CL
[J]. NATURE MEDICINE, 2004, 10 (01) : 33 - 39
[2] The development of androgen-independent prostate cancer
Feldman, BJ
Feldman, D
[J]. NATURE REVIEWS CANCER, 2001, 1 (01) : 34 - 45
[3] Androgen receptor signaling in androgen-refractory prostate cancer
Grossmann, ME
Huang, HJ
Tindall, DJ
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (22): : 1687 - 1697